Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

871.00INR
3 Jul 2015
Change (% chg)

Rs-0.10 (-0.01%)
Prev Close
Rs871.10
Open
Rs874.40
Day's High
Rs881.70
Day's Low
Rs868.75
Volume
1,407,939
Avg. Vol
8,718,973
52-wk High
Rs1,200.80
52-wk Low
Rs693.40

SUN.NS

Chart for SUN.NS

About

Sun Pharmaceutical Industries Ltd. (Sun) is a specialty pharmaceutical company. The Company manufactures and markets a range of pharmaceutical formulations as branded generics, as well as generics, in the United States, India and other markets. It operates through four segments: US Generics, Indian Branded Generics, Internationa... (more)

Overall

Beta: 0.56
Market Cap(Mil.): Rs2,095,995.00
Shares Outstanding(Mil.): 2,406.42
Dividend: 1.50
Yield (%): 0.17

Financials

  SUN.NS Industry Sector
P/E (TTM): 39.73 35.83 39.81
EPS (TTM): 21.92 -- --
ROI: 21.05 17.03 16.23
ROE: 20.17 17.93 17.36
Search Stocks

Indian shares rangebound; IT firms fall, Sun Pharma shines

MUMBAI, June 30 - Indian shares traded rangebound on Tuesday as software exporters such as Tata Consultancy Services fell after revenue warnings by some of its smaller rivals, while Sun Pharmaceutical Industries rose after Credit Suisse said the company has raised prices of some drugs.

30 Jun 2015

BUZZ-India's Sun Pharma rises; Credit Suisse says Ranbaxy drug prices hiked

** Company hikes prices in unit Ranbaxy Laboratories' US-branded portfolio - Credit Suisse

30 Jun 2015

Nifty posts worst weekly loss in 3-1/2 years

MUMBAI - The Nifty fell for a fifth consecutive session on Friday to post its worst weekly fall since December 2011, continuing to reel after a forecast for weaker-than-expected monsoon raised fears the Reserve Bank of India (RBI) would not cut rates again this year.

05 Jun 2015

Indian shares edge up after recent losses; blue chips gain

MUMBAI, June 5 - India's NSE index rose 0.2 percent on Friday, snapping a four-session losing streak as investors saw some of the blue chips such as Sun Pharmaceutical Industries as oversold even as broader sentiment remained cautious.

05 Jun 2015

Sensex ends flat ahead of RBI review; Sun Pharma slumps

MUMBAI - The BSE Sensex ended broadly unchanged, as hopes the central bank would cut interest rates this week lifted some rate-sensitive firms, but Sun Pharmaceutical Industries slumped after posting disappointing earnings.

01 Jun 2015

Indian shares end flat ahead of RBI review; Sun Pharma slumps

MUMBAI, June 1 - Indian shares ended broadly unchanged, as hopes the central bank would cut interest rates this week lifted some rate-sensitive firms, but Sun Pharmaceutical Industries slumped after posting disappointing earnings.

01 Jun 2015

Indian shares edge up ahead of RBI review; Sun Pharma slumps

MUMBAI, June 1 - Indian shares edged up on Monday, heading for a second straight session of gains, as hopes the central bank would cut interest rates this week lifted interest rate-sensitive firms such as State Bank of India.

01 Jun 2015

BUZZ-India's Sun Pharma slumps as much as 10 pct on Q4 results

** Sun Pharmaceutical Industries slumps as much as 10 pct to 869.10 rupees as of 0445 GMT, its lowest since Feb. 27

01 Jun 2015

Sun Pharma misses profit estimates on Ranbaxy costs

MUMBAI - Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, reported fourth-quarter profit well below analysts' expectations, hit by costs related to integrating smaller rival Ranbaxy Laboratories Ltd.

29 May 2015

India's Sun Pharma misses profit estimates on Ranbaxy costs

MUMBAI, May 29 - Sun Pharmaceutical Industries Ltd , India's largest drugmaker by sales, reported fourth-quarter profit well below analysts' expectations, hit by costs related to integrating smaller rival Ranbaxy Laboratories Ltd.

29 May 2015

Earnings vs. Estimates

Search Stocks